Liminal BioSciences
Laval
About Liminal BioSciences
Liminal BioSciences is a biopharmaceutical corporation supplying state-of-the-art technologies for bio-separations as well as therapeutic products. It specializes in discovering, developing, and commercializing novel small molecule compounds for respiratory, liver, and renal diseases. The company focuses specifically on developing solutions for rare and orphan diseases. Liminal BioSciences was founded in 1992 and is headquartered in Laval, Quebec.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $1K – $10K
- Total funding: $149.6M
- Funding stage: M&A
- Last round: Post-IPO Equity (Jul 2020)
- Ticker: nasdaq:LMNL
- Website: liminalbiosciences.com
- Phone: 1(450)781-0115
Industries & Categories
Biotechnology, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/liminal-biosciences-197244 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.